NT-proBNP and sRAGE levels in early rheumatoid arthritis.
S C HeslingaCharlotte E TeunissenRabia AgcaDiane van der WoudeThomas Wj HuizingaJacob M van LaarAlfons A den BroederWillem F LemsMichael T NurmohamedPublished in: Scandinavian journal of rheumatology (2022)
Suppressing inflammation, independently of achieving remission, increases sRAGE levels and decreases NT-proBNP levels significantly. Whether this translates into a decrease in incident cardiovascular disease remains to be elucidated.